v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:          
Net income (loss) $ (3,976,339) $ (813,043) $ (7,671,859) $ 3,257,789  
Adjustments to reconcile net income (loss) to net cash (used in) operating activities:          
Gain on bargain purchase (5,602,484)  
Gain on removal of permitted sites     (2,444)  
Net (gain) loss on asset disposals 2,039 24,582 2,039 (1,085)  
Deficiency claims on returned equipment     (78,536) 560,402  
Credit loss on note receivable 1,812,183 1,812,183  
Fair value of vested stock options     132,500 168,980  
Depreciation from continuing operations     43,002 58,473 $ 78,383
Depreciation from discontinued operations     91,908 91,908
Amortization of long-term intangible assets 799,109 367,285 2,371,268 731,452  
Accretion of asset retirement obligations     4,459,941 1,250,799  
Changes in operating assets and liabilities:          
Accounts receivable     (748,719) (423,849)  
Accounts receivable from discontinued operations     227,241  
Notes receivable     (1,812,183)  
Contract assets     154,354  
Prepaid expenses and other current assets     (45,326) (24,174)  
Deposits     3,404 (15,395)  
Accounts payable     (37,550) (57,351)  
Deferred revenue     229,167  
Accrued expenses     (29,919)  
Long-term deposits     (1,000,000)  
Cash paid for asset retirement obligations     (3,782,054) (1,079,452)  
Net cash (used in) operating activities     (6,122,723) (734,755)  
Cash flows from investing activities:          
Equipment purchases     (37,006) (100,000)  
Investment in software development costs     (191,800)  
Proceeds from asset sales     525,000  
Net cash provided by (used in) investing activities     (228,806) 425,000  
Cash flows from financing activities:          
Proceeds from stock issuance     5,192,500 1,150,000  
Repayment of line of credit     (200,000)  
Repayment of long-term debt     (300,000) (522,143)  
Net cash provided by financing activities     4,892,500 427,857  
Net (decrease) in cash and cash equivalents     (1,459,029) 118,102  
Cash and cash equivalents - beginning of period     2,110,171 167,286 167,286
Cash and cash equivalents - end of period $ 651,142 $ 285,388 651,142 285,388 $ 2,110,171
Cash paid during the period for:          
Interest     100,513 148,810  
Supplemental schedule of Non-Cash Investing and Financing Activities:          
Conversion of noncontrolling equity interest to additional paid-in capital     16,326,016  
Conversion of line of credit and short term note to bank term loan     1,800,000  
Debt reduction from equipment returned to lender     $ 914,803